Fangshun Tan
Hubei Key Laboratory Of Tumor Microenvironment And Immunotherapy
Xiaoxita, 443002, China
Xiaoxita, 443002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseases.
Journal: Journal of physiology and biochemistry
Published: January 19, 2024
The Pivotal Function of SLC16A1 and SLC16A1-AS1 in Cancer Progress: Molecular Pathogenesis and Prognosis.
Journal: Mini reviews in medicinal chemistry
Published: October 27, 2023
Application of Nanomedicine in Tumor Targeting Inflammatory Pathway.
Journal: Current medicinal chemistry
Published: August 14, 2023
The regulatory role of LncRNA HCG18 in various cancers.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: May 11, 2022
Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
Journal: Current medicinal chemistry
Published: April 12, 2022
The Dual Functions of Non-Coding RNA CRNDE in Different Tumors.
Journal: Mini reviews in medicinal chemistry
Published: March 09, 2022
ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple Cancer Types.
Journal: Mini reviews in medicinal chemistry
Published: February 11, 2022
MEG8: An Indispensable Long Non-coding RNA in Multiple Cancers.
Journal: Current pharmaceutical design
Published: November 02, 2021
MIR4435-2HG: A Tumor-associated Long Non-coding RNA.
Journal: Current pharmaceutical design
Published: October 25, 2021
HNF1A-AS1: A Tumor-associated Long Non-coding RNA.
Journal: Current pharmaceutical design
Published: October 25, 2021
LncRNA SBF2-AS1: A Budding Star in Various Cancers.
Journal: Current pharmaceutical design
Published: October 05, 2021
ITGA9: Potential Biomarkers and Therapeutic Targets in Different Tumors.
Journal: Current pharmaceutical design
Published: September 01, 2021
Last Updated: 09/26/2026